Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Clinical Trial Comparing Serum Mast Cell Tryptase (SMCT) Levels to Arthrofibrosis Rates Among Primary Total Knee Arthroplasty (TKA) Patients

NCT03598829 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03598829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03598829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Clinical Trial Comparing Serum Mast Cell Tryptase (SMCT) Levels to Arthrofibrosis Rates Among Primary Total Knee Arthroplasty (TKA) Patients
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Completed
Start date
July 1, 2018
Completion date
November 15, 2023
Enrollment
219 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arthrofibrosis, arthropathy of knee, knee osteoarthritis